New legislation would stop Big Pharma from blindsiding residents with price hikes.
Patients For Affordable Drugs Now releases new video to support the Trump administration's International Pricing Index.
As the price of specialty drugs explodes, more and more Americans are going without the prescriptions they need, data from two new government reports show.
High drug prices mean multitudes of millions for CEOs like David Ricks of Eli Lilly and Richard Gonzalez of AbbVie.
Measure would shed light on drug pricing practices and protect Washington residents
American patients are standing inside a burning house, and Congress needs to pick up the firehose.
Four Common-Sense Proposals Enjoy Bipartisan Support.
Maryland lawmakers can take a stand today on one of the most important issues facing residents — rising prescription drug prices.
Big Pharma’s price hikes are under the microscope of the Senate Aging Committee this week with a hearing featuring patients hurt by the skyrocketing costs of their medicines.
Patients are harmed because high-priced drugs have consequences.
Measure would save money for Utah patients and taxpayers.
We appreciate President Trump’s continued focus on the country’s drug pricing crisis. But, two years into his term, prices are still going up, patients are still struggling, and Big Pharma is breaking records lobbying Congress to keep it that way.
Patient whose Part B drug costs led to bankruptcy supports Trump Administration and urges Congress to support the International Pricing Index.
The drug lobby’s arguments against holding down prices in Medicare Part B just don’t add up.
3 questions to ask the drug lobby about Medicare Part B
Patients For Affordable Drugs Now Takes Major Action in Support of International Pricing Index and Medicare Part B Reforms.